Search - tctmd.com

Displaying 821 - 840 of 965

Sort: Relevancy | Date

Presentation TCT 2014

The CoreValve US Pivotal Trial: Two-Year Results with a Self-Expanding Bioprosthesis in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Robert J. Applegate, Ronald Caputo, Steven J. Yakubov

September 13, 2014

Presentation TCT 2014

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

Presenter: Patrick W. Serruys, David J. Cohen, Axel Linke

September 13, 2014

Presentation TCT 2014

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Matthew R. Reynolds

September 13, 2014

Presentation TCT 2014

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Presenter: Patrick W. Serruys, David J. Cohen, Samir R. Kapadia

September 13, 2014

Presentation TCT 2014

Hemodynamics of Aortic Stenosis and Live Calculations Using the Telestrator

Presenter: Thomas H. Maloney, John R. Zimmerman, Tim J. Lapp

September 13, 2014

News Conference News TCT 2014

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

Todd Neale

September 13, 2014

News Conference News TCT 2014

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

September 13, 2014

News Conference News TCT 2014

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Yael L. Maxwell

September 13, 2014

News Conference News TCT 2014

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

September 13, 2014

News Conference News TCT 2014

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

September 13, 2014

News Conference News TCT 2013

Regadenoson Shows Promise in Measuring Fractional Flow Reserve

November 07, 2013

News Conference News TCT 2013

Clamping Intolerance Predicted by Low Clamping Pressure in Carotid Stenting

November 07, 2013

News Conference News TCT 2013

TAVR a Viable Option for Intermediate-Risk Patients

November 05, 2013

Presentation TCT 2013

REPRISE II: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Presenter: Ian Meredith

October 31, 2013

Presentation TCT 2013

Contemporary Strategies for Congenital Valvular and Conduit Stenosis

Presenter: John P. Cheatham

October 31, 2013

Presentation TCT 2013

Case #5 - Multivessel Disease and Aortic Stenosis: Therapy Selection and Sequence

Presenter: George Latsios

October 31, 2013

Presentation TCT 2013

Basal Stenosis Resistance Index: Background, Physiologic Rationale, and Clinical Data

Presenter: Tim van de Hoef

October 31, 2013

News Conference News TCT 2013

Second-Generation TAVR Device Overcomes Issues of Current Valves

October 31, 2013

Presentation TCT 2013

Management of Pregnancy in Mitral Stenosis

Presenter: Linda Gillam

October 30, 2013

Presentation TCT 2013

Current Results With Surgical Repair of Mitral Stenosis: A Pretty Good Operation!

Presenter: Neil Moat

October 30, 2013

Advertisement

The CoreValve US Pivotal Trial: Two-Year Results with a Self-Expanding Bioprosthesis in Extremely High-Risk Patients with Aortic Stenosis

CLEAN-TAVI: A Prospective, Randomized Trial of Cerebral Embolic Protection in High-Risk Patients with Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement

US CoreValve High Risk Trial: Cost-Effectiveness Analysis From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Self-Expanding Device Versus Surgical Aortic Valve Replacement in High-Risk Patients with Aortic Stenosis

PARTNER I: Five-Year Results From a Prospective, Randomized Trial of Transcatheter Aortic Valve Replacement with a Balloon-Expandable Device Versus Conservative Care in Extremely High-Risk Patients with Aortic Stenosis

Hemodynamics of Aortic Stenosis and Live Calculations Using the Telestrator

TAVR Effective in High-Risk Patients at ‘Acceptable’ Cost

PEPCAD-DES at 3 Years: Paclitaxel-Coated Balloon Holds Advantage for DES Restenosis

PARTNER Shows Clear TAVR Benefit at 5 Years in Inoperable Patients

Disparity Seen Between Aortic Valve-in-Valve Implantation for Stented, Stentless Devices

Bleeding, Arrhythmias Dominate Periprocedural Complication Costs for TAVR

Regadenoson Shows Promise in Measuring Fractional Flow Reserve

Clamping Intolerance Predicted by Low Clamping Pressure in Carotid Stenting

TAVR a Viable Option for Intermediate-Risk Patients

REPRISE II: A Prospective Registry Study of Transcatheter Aortic Valve Replacement with a Repositionable Transcatheter Heart Valve in Patients with Severe Aortic Stenosis

Contemporary Strategies for Congenital Valvular and Conduit Stenosis

Case #5 - Multivessel Disease and Aortic Stenosis: Therapy Selection and Sequence

Basal Stenosis Resistance Index: Background, Physiologic Rationale, and Clinical Data

Second-Generation TAVR Device Overcomes Issues of Current Valves

Management of Pregnancy in Mitral Stenosis

Current Results With Surgical Repair of Mitral Stenosis: A Pretty Good Operation!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content